Location: New York, NY
CIK: 0001482416 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 13, 2025
Total Value: $262M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MMS | MAXIMUS INC | 548,086 | $38.48M | 14.7% | $80.50 | -12.7% | COM | 577933104 |
| IRON | DISC MEDICINE INC | 284,787 | $15.08M | 5.8% | $43.62 | +7.7% | COM | 254604101 |
| GMED | GLOBUS MED INC | 245,570 | $14.49M | 5.5% | $79.80 | -19.0% | CL A | 379577208 |
| CNC | CENTENE CORP DEL | 262,500 | $14.25M | 5.4% | $58.65 | 0.0% | COM | 15135B101 |
| MRK | MERCK & CO INC | 173,951 | $13.77M | 5.3% | $90.12 | -14.1% | COM | 58933Y105 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 512,338 | $13.38M | 5.1% | $35.35 | -15.2% | COM NEW | 10919W405 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 100,725 | $12.66M | 4.8% | $126.68 | -9.5% | COM | 64125C109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 225,114 | $12.37M | 4.7% | $64.15 | -8.2% | COM | 09061G101 |
| ANNX | ANNEXON INC | 4,095,764 | $9.83M | 3.8% | $4.66 | -57.0% | COM | 03589W102 |
| IDXX | IDEXX LABS INC | 18,000 | $9.654M | 3.7% | — | — | Put | 45168D104 |
| SNY | SANOFI | 187,500 | $9.058M | 3.5% | $48.31 | — | SPONSORED ADR | 80105N105 |
| TYRA | TYRA BIOSCIENCES INC | 810,274 | $7.754M | 3.0% | $12.32 | -22.9% | COM | 90240B106 |
| ANIP | ANI PHARMACEUTICALS INC | 112,923 | $7.368M | 2.8% | $59.16 | +10.1% | COM | 00182C103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 539,730 | $7.076M | 2.7% | $14.42 | 0.0% | COM | 28036F105 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 1,839,022 | $6.97M | 2.7% | $5.59 | -27.3% | COM | 03675P102 |
| SEPN | SEPTERNA INC | 584,435 | $6.177M | 2.4% | $15.63 | -47.3% | COM | 81734D104 |
| AORT | ARTIVION INC | 158,736 | $4.937M | 1.9% | $26.24 | +3.1% | COM | 228903100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 236,070 | $4.398M | 1.7% | $20.39 | -8.0% | COM | 252828108 |
| PRQR | PROQR THERAPEUTICS N V | 2,075,139 | $4.233M | 1.6% | $3.16 | -48.5% | SHS EURO | N71542109 |
| PMVP | PMV PHARMACEUTICALS INC | 3,735,396 | $3.96M | 1.5% | $1.73 | -43.2% | COM | 69353Y103 |
| AVNS | AVANOS MED INC | 288,849 | $3.536M | 1.4% | $15.58 | -19.3% | COM | 05350V106 |
| — | MERUS N V | 62,719 | $3.299M | 1.3% | $52.60 | — | COM | N5749R100 |
| AQST | AQUESTIVE THERAPEUTICS INC | 947,489 | $3.136M | 1.2% | $2.93 | -2.2% | COM | 03843E104 |
| INMB | INMUNE BIO INC | 1,299,300 | $3.001M | 1.1% | — | — | Put | 45782T105 |
| VTYX | VENTYX BIOSCIENCES INC | 1,307,964 | $2.799M | 1.1% | $2.68 | -39.7% | COM | 92332V107 |
| MBX | MBX BIOSCIENCES INC | 241,000 | $2.75M | 1.1% | $10.19 | 0.0% | COM | 55287L101 |
| IDYA | IDEAYA BIOSCIENCES INC | 124,230 | $2.611M | 1.0% | $37.74 | -49.2% | COM | 45166A102 |
| ALGS | ALIGOS THERAPEUTICS INC | 335,937 | $2.422M | 0.9% | $14.55 | -58.9% | COM NEW | 01626L204 |
| VIR | VIR BIOTECHNOLOGY INC | 478,343 | $2.411M | 0.9% | $7.89 | -32.0% | COM | 92764N102 |
| NMTC | NEUROONE MED TECHNOLOGIES CO | 3,523,663 | $2.39M | 0.9% | $0.62 | 0.0% | COM NEW | 64130M209 |
| — | SENSEONICS HLDGS INC | 4,852,298 | $2.312M | 0.9% | $0.48 | — | COM | 81727U105 |
| TVTX | TRAVERE THERAPEUTICS INC | 122,210 | $1.809M | 0.7% | $20.26 | -18.2% | COM | 89422G107 |
| ERAS | ERASCA INC | 1,369,748 | $1.74M | 0.7% | $2.02 | -33.7% | COM | 29479A108 |
| — | ASTRIA THERAPEUTICS INC | 318,256 | $1.706M | 0.7% | $13.10 | — | COM | 04635X102 |
| SVRA | SAVARA INC | 726,851 | $1.657M | 0.6% | $2.76 | -1.6% | COM | 805111101 |
| ENTA | ENANTA PHARMACEUTICALS INC | 178,774 | $1.352M | 0.5% | $13.23 | -54.5% | COM | 29251M106 |
| TELA | TELA BIO INC | 636,300 | $1.234M | 0.5% | $2.80 | -53.2% | COM | 872381108 |
| ALEC | ALECTOR INC | 845,531 | $1.184M | 0.5% | $3.18 | -60.6% | COM | 014442107 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,341,636 | $879K | 0.3% | $1.71 | -58.0% | COM | 21077P108 |
| OVID | OVID THERAPEUTICS INC | 2,232,000 | $736K | 0.3% | $0.84 | -64.2% | COM | 690469101 |
| MODD | MODULAR MED INC | 785,824 | $585K | 0.2% | $1.38 | -35.3% | COM NEW | 60785L207 |
| FHTX | FOGHORN THERAPEUTICS INC | 122,889 | $578K | 0.2% | $4.31 | -3.1% | COM | 344174107 |
| APRE | APREA THERAPEUTICS INC | 279,369 | $472K | 0.2% | $7.27 | -76.6% | COM NEW | 03836J201 |
| NYXH | NYXOAH S A | 50,839 | $380K | 0.1% | $7.82 | -12.1% | SHS | B6S7WD106 |
| AVTX | AVALO THERAPEUTICS INC | 72,173 | $360K | 0.1% | $11.82 | -60.5% | COM NEW | 05338F306 |
| EMBC | EMBECTA CORP | 31,169 | $302K | 0.1% | $15.40 | -29.3% | COMMON STOCK | 29082K105 |
| BOLD | BOUNDLESS BIO INC | 163,679 | $165K | 0.1% | $13.58 | -90.2% | COM | 10170A100 |
| — | NEXTCURE INC | 131,300 | $60,398 | 0.0% | $5.95 | — | COM | 65343E108 |
| TERN | TERNS PHARMACEUTICALS INC | 10,100 | $37,673 | 0.0% | $8.18 | -61.8% | COM | 880881107 |
| HUMAW | HUMACYTE INC | 49,998 | $18,749 | 0.0% | $0.60 | — | *W EXP 08/27/202 | 44486Q111 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 400,000 | $13,620 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |
| ATYR | ATYR PHARMA INC | 1,100 | $5,577 | 0.0% | — | — | Put | 002120202 |